SDZ 210-086
SDZ 210-086 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a selective antagonist of the neurokinin-1 receptor (NK1 receptor), which is involved in various physiological processes, including the modulation of pain and the regulation of mood.
Pharmacology[edit | edit source]
SDZ 210-086 acts by selectively blocking the NK1 receptor, which is a receptor for the neuropeptide substance P. Substance P is a key player in the transmission of pain signals and is also implicated in the pathophysiology of depression and anxiety disorders. By inhibiting the action of substance P, SDZ 210-086 may have potential therapeutic applications in the treatment of these conditions.
Mechanism of Action[edit | edit source]
The NK1 receptor is a G protein-coupled receptor that, upon binding with substance P, activates intracellular signaling pathways that lead to the sensation of pain and the modulation of mood. SDZ 210-086 binds to the NK1 receptor, preventing substance P from exerting its effects, thereby potentially reducing pain perception and alleviating symptoms of mood disorders.
Clinical Research[edit | edit source]
Research on SDZ 210-086 has primarily focused on its potential use in treating chronic pain, depression, and anxiety. Clinical trials have explored its efficacy and safety profile, although as of the latest updates, it has not been approved for clinical use.
Chemical Properties[edit | edit source]
SDZ 210-086 is characterized by its specific chemical structure, which allows it to selectively bind to the NK1 receptor. Detailed studies of its chemical properties are essential for understanding its pharmacokinetics and pharmacodynamics.
Potential Applications[edit | edit source]
The potential applications of SDZ 210-086 extend beyond pain management and mood disorders. Ongoing research is investigating its role in other conditions where substance P and NK1 receptors are implicated, such as chemotherapy-induced nausea and vomiting (CINV).
Safety and Side Effects[edit | edit source]
As with any pharmacological agent, the safety profile of SDZ 210-086 is a critical aspect of its development. Studies have reported various side effects, which need to be carefully evaluated in the context of its therapeutic benefits.
Also see[edit | edit source]
- Neurokinin-1 receptor antagonist
- Substance P
- Chronic pain management
- Depression treatment
- Anxiety disorder
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
